New drug for Alzheimer’s disease shows promise in phase 3 trial
Sep 28, 2022
Lecanemab is a monoclonal antibody drug designed to target and help remove Alzheimer’s-associated amyloid plaques in the brain.
Older adults with cognitive impairment at risk for financial exploitation: study
By
Kimberly Bonvissuto
Sep 15, 2022
Among the estimated 50 million adults 65 and older in the nation, 20% have a form of cognitive impairment. And many of those individuals live alone and are having difficulty managing their finances, leaving...
‘Significant’ drop in residential care aide workforce during pandemic raises questions about future...
By
Kimberly Bonvissuto
Sep 08, 2022
The residential care aide workforce — personal care aides, home health aides and nursing assistants who work in assisted living communities, continuing care retirement / life plan communities and other...
More news for Monday, Aug. 8
By
Kimberly Bonvissuto
Aug 08, 2022
$25 million in COVID-19 payments will support 211 long-term care organizations … As long-term care job vacancies approach 30%, report suggests solutions … Frontline nurses likely to leave profession...
Effect of noradrenergic drugs explored in Alzheimer’s disease
Jul 29, 2022
Meta-analyses suggest positive effects of noradrenergic drugs on global cognition and apathy.
Exercise, chores, social visits linked to lower dementia risk
Jul 28, 2022
Comparable results were seen for dementia, vascular dementia, Alzheimer’s disease, and in analyses stratified by dementia polygenic risk score.
New Alzheimer’s disease drug delivers disappointing results
Jun 17, 2022
The trial was the first to test a drug meant to delay or halt mental decline in people who have a genetic predisposition.
Medicare spending spikes for dementia diagnoses in seniors
Jun 13, 2022
Medicare spending was higher for adults with a formal clinical diagnosis of dementia versus a positive screening for cognitive impairment.
Assisted living providers struggled with infection control during pandemic, multistate study reveals
By
Alicia Lasek
Jun 09, 2022
Assisted living operators reported serious challenges in implementing infection prevention and control practices for residents living with dementia during the COVID-19 pandemic, according to a new study.
Memory care, falls prevention studies secure nearly $35 million in grant funding
By
Kimberly Bonvissuto
May 31, 2022
Researchers have secured close to a total of $35 million across multiple U.S. studies to identify falls prevention strategies and risk factors for cognitive decline, as well as expand a dementia-specific...